INS and Parkinson disease: Therefore, the specific characterization of the molecular mechanisms involved in PD pathogenesis through the impairment of insulin signaling, UPS, and the PI3K/Akt/GSK-3 pathway could help to develop new therapeutic options and improve the diagnosis.